Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zoetis Inc ZTS

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a... see more

Recent & Breaking News (NYSE:ZTS)

Zoetis to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference

Business Wire May 13, 2016

Zoetis Declares Third Quarter 2016 Dividend

Business Wire May 12, 2016

Zoetis Holds Annual Meeting of Shareholders

Business Wire May 12, 2016

Zoetis Reports First Quarter 2016 Results

Business Wire May 4, 2016

Zoetis to Participate in the BMO Capital Markets 11th Annual Farm to Market Conference

Business Wire April 20, 2016

Zoetis to Participate in the Deutsche Bank 41st Annual Health Care Conference

Business Wire April 7, 2016

Zoetis to Host Webcast and Conference Call on First Quarter 2016 Financial Results

Business Wire March 31, 2016

Forbes Names Zoetis One of America's Best Employers

Business Wire March 23, 2016

Zoetis to Participate in the Jefferies Animal Health Summit

Business Wire March 4, 2016

Zoetis Receives FDA Approval for SimparicaTM (sarolaner) Chewables, a Once-Monthly Flea and Tick Medication for Dogs

Business Wire February 25, 2016

Zoetis Declares Second Quarter 2016 Dividend

Business Wire February 19, 2016

Zoetis to Participate in the Barclays Global Healthcare Conference

Press Releases February 17, 2016

13F from JANA Shows Liquidated Position in Zoetis

Press Releases February 16, 2016

Zoetis Sees Full Year 2017 Revenue Guidance to $4.950 - $5.150 Billion and Reaffirms Adjusted Diluted EPS of $2.18 - $2.32

Press Releases February 16, 2016

Zoetis Sees Full Year 2016 Revenue Guidance to $4.650 - $4.775 vs. Est. $4.82B Billion and Reaffirms Adjusted Diluted EPS of $1.71 - $1.81 vs. Est. $1.81

Press Releases February 16, 2016

Zoetis Reports Q4 EPS $0.43 vs. Est. $0.39, Rev. $1.3B vs. Est. $1.25B

Press Releases February 16, 2016

Build A Bear Reiterates Guidance

Press Releases February 16, 2016

Zoetis Reports Fourth Quarter and Full Year 2015 Results

Press Releases February 16, 2016

Technicals Behind the Moving Prices -- Complementary Research on Western Digital, Zoetis, Travelers Companies and PVH Corp.

Accesswire February 9, 2016

Zoetis Comments on European Commission Decision Regarding Belgium Tax Rulings; Provides Preliminary Update of Financial Guidance for 2016 and 2017

Business Wire January 12, 2016